Bruce Japsen

Summary Cigna Group's Evernorth health services is investing $100 million through 2028 into an AI-powered "Pharmacy Forward" program to revolutionize specialty care access and patient experience. This initiative addresses the rising costs of specialty drugs, which account for over half of prescription spending. Launching first with Accredo Specialty Pharmacy, the program aims to deliver personalized, proactive support by combining real-time data and advanced analytics. It will reduce prescription processing timelines, improve service responsiveness, and ensure more reliable, efficient shipping, with over 90% of patients receiving same/next-day ground delivery. The goal is to empower care teams to focus on clinical care and achieve better health outcomes for patients with complex conditions.

The Cigna Group's Evernorth health services business is making a $100 million investment through 2028 to support a new artificial intelligence-powered

Peak Rock Capital has acquired Asembia, a fast-growing provider of specialty pharmacy services, including distribution, group purchasing, and technology connecting patients. Founded in 2004, Asembia addresses the specialized needs of medicines that now comprise over 60% of employer drug spending, particularly with the rise of GLP-1s. Asembia CEO Lawrence Irene stated Peak Rock's investment will fuel growth, technology, and innovation, improving experiences for patients, prescribers, and partners. The company has evolved to offer crucial technology solutions, exemplified by its ASPN digital retail network. This platform streamlines patient access to therapies by connecting drug makers, prescribers, and pharmacies, effectively reducing barriers like financial hurdles and prior authorizations.

News The Cigna Group's Evenorth health services business has committed $100 million to support a new artificial intelligence-powered pharmacy program

Health insurers are proposing another year of double-digit premium increases for individual coverage under the Affordable Care Act in 2027, with a KFF analysis showing a median 14% hike. This follows a 58% average out-of-pocket premium increase in 2026, potentially pushing typical premiums up over one-third in two years. Rising health service costs and the expiration of enhanced premium tax credits are cited as key drivers. The loss of these credits has already led to over 2 million Americans dropping coverage and created market turbulence. Major insurers like Cigna and CVS Health are exiting the ACA marketplace, while Centene and UnitedHealthcare report significant enrollment declines, signaling a challenging outlook for enrollees.

Cigna’s $100 million investment to support a new AI-powered pharmacy program and Peak Rock Capital's purchase of Asembia may spur even more specialty pharmacy deals.

Peak Rock Capital bought Asembia, a provider of services surrounding specialty pharmacy including distribution, group purchasing and technology connecting patients.

Cigna’s Evernorth health is investing $100 million to support a new AI-powered program designed to improve how patients access and experience specialty pharmacy.

Health insurance giants Elevance Health and UnitedHealth Group are set to release their second-quarter earnings this week, with the industry closely watching for signs of sustained control over escalating medical costs. After a period in 2025 where many insurers reported medical loss ratios exceeding 90%, the first quarter of 2026 showed promising improvements, with Elevance at 86.8% and UnitedHealth at 83.9%. These upcoming reports, from the nation's largest and second-largest insurers, will offer crucial clues on whether the sector is truly turning a corner. Analysts are optimistic, particularly regarding continued cost management within profitable Medicare Advantage plans, as these companies navigate a challenging healthcare landscape.

Elevance Health reported second-quarter net income of $1.45 billion, or $6.71 per share, a 13% decrease from the prior year. Despite this decline, the health insurer raised its full-year earnings outlook to "at least $20.10" per share, citing favorable benefit expense performance and strong operating results. CEO Gail K. Boudreaux highlighted disciplined execution across their diversified portfolio, which includes Anthem Blue Cross Blue Shield plans. While the company's benefit expense ratio still increased to 89.7% due to elevated medical costs in government businesses, improved individual ACA performance offered some offset. Total revenue grew 1.4% to $50.47 billion, though membership saw a slight dip to 44.9 million.